Predictions
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.30
14.12.20
14.12.20
-
14.12.21
14.12.21
169.86%
07.07.21
07.07.21
Probably not worthwhile Investment
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.20
14.12.20
14.12.20
€11.00
14.12.21
14.12.21
15.85%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Biocardia Inc.
Start price
Target price
Perf. (%)
€4.53
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-24.50%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.90
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
158.23%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Synlogic Inc.
Start price
Target price
Perf. (%)
€3.00
14.12.20
14.12.20
€3.00
14.12.21
14.12.21
0.00%
29.01.21
29.01.21
Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
Navya S.a.
Start price
Target price
Perf. (%)
€3.86
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-42.05%
15.12.21
15.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Aim Immunotech Inc.
Start price
Target price
Perf. (%)
€1.51
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
-35.89%
15.12.21
15.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Hensoldt AG
Start price
Target price
Perf. (%)
€13.99
13.12.20
13.12.20
-
13.12.21
13.12.21
-11.94%
14.12.21
14.12.21
Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ming Le Sports AG
Start price
Target price
Perf. (%)
€1.27
13.12.20
13.12.20
€1.00
13.12.21
13.12.21
77.95%
03.04.21
03.04.21
Top 10 in its market
Future proof or reliable business model
Good rating
High risks for its business
Up Fintech Holding Ltd.
Start price
Target price
Perf. (%)
€4.74
13.12.20
13.12.20
€28.00
23.10.24
23.10.24
-18.57%
06.01.22
06.01.22
Rainforest Resources Inc.
Start price
Target price
Perf. (%)
€2.08
12.12.20
12.12.20
-
7.69%
15.12.20
15.12.20
Risky Investment
Business model of the past or high risk
Little known brand
thyssenkrupp AG ADR
Start price
Target price
Perf. (%)
€6.15
05.12.20
05.12.20
-
05.12.21
05.12.21
85.37%
27.02.21
27.02.21
Top 10 in its market
Probably not worthwhile Investment
Significant cyclical dependencies
Business model of the past or high risk
Sibanye Stillwater Ltd.
Start price
Target price
Perf. (%)
€3.00
05.12.20
05.12.20
€3.50
05.12.21
05.12.21
-6.36%
06.12.21
06.12.21
Could be very worthwhile Investment >20% year
Fastly Inc.
Start price
Target price
Perf. (%)
€74.50
05.12.20
05.12.20
€75.00
8.05%
08.12.20
08.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Everfuel A/S
Start price
Target price
Perf. (%)
€6.20
28.11.20
28.11.20
-
28.11.21
28.11.21
83.06%
16.02.21
16.02.21
Business model of the past or high risk
Below average Marketposition
Risky Investment
Significant cyclical dependencies
Plastiques Du Val De Loire Sa
Start price
Target price
Perf. (%)
€6.09
28.11.20
28.11.20
€7.00
28.11.21
28.11.21
-3.78%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year
STS Group AG
Start price
Target price
Perf. (%)
€4.82
27.11.20
27.11.20
-
-5.39%
11.12.20
11.12.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
STS Group AG
Start price
Target price
Perf. (%)
€4.61
27.11.20
27.11.20
€5.00
4.56%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Navya S.a.
Start price
Target price
Perf. (%)
€4.50
26.11.20
26.11.20
€5.00
-29.33%
26.01.21
26.01.21
Risky Investment
STS Group AG
Start price
Target price
Perf. (%)
€4.56
25.11.20
25.11.20
€5.00
1.10%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Ecmoho Ltd.
Start price
Target price
Perf. (%)
€2.10
24.11.20
24.11.20
-
24.11.21
24.11.21
-34.76%
02.06.21
02.06.21
Probably not worthwhile Investment
Fastly Inc.
Start price
Target price
Perf. (%)
€71.50
20.11.20
20.11.20
€74.00
4.20%
05.12.20
05.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation